<DOC>
	<DOCNO>NCT00395343</DOCNO>
	<brief_summary>A clinical study determine safety efficacy sitagliptin patient Type 2 Diabetes Mellitus inadequate glycemic control insulin insulin/metformin combination therapy .</brief_summary>
	<brief_title>Sitagliptin Added-on Insulin Study ( 0431-051 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patient type 2 diabetes mellitus Patient poorly control insulin insulin metformin Patient history type 1 diabetes mellitus history ketoacidosis Patient take oral antidiabetic agent metformin past 3 month Patient currently treatment daily use preprandial shortacting rapidacting insulin</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>